摘要
目的:探讨大剂量盐酸氨溴索配伍鼻塞式持续气道正压通气(NCPAP)对Ⅰ～Ⅱ级早产儿肺透明膜病(HMD)的治疗作用。方法:给31例患HMD的早产儿静滴大剂量盐酸氨溴索30mg/(kg·d),同时给予NCPAP呼吸支持治疗。结果:31例患儿在联合治疗1～2h后血氧饱和度均上升至90%左右,呼吸窘迫明显缓解,皮肤转红润,三凹征减轻。结论:大剂量盐酸氨溴索配伍NCPAP能有效治疗I～Ⅱ级早产儿肺透明膜病。
Objective：To investigate the effect of treatment of using large dose of ambroxol hydrochloride capsules with nasal continuous positive airway pressure（NCPAP） on hyaline membrane disease in Ⅰ-Ⅱ grade premature infant.Methods：A total of 31 premature infants with hyaline membrane disease were treated by large dose of ambroxol hydrochloride capsules with NCPAP.Results：31 patients were clinical improved with SpO2 rising to about 90%,respiratory embarrassment and three depressions sign released.Conclusion：Large dose of ambroxol hydrochloride capsules with NCPAP has a curing effect on hyaline membrane disease in Ⅰ-Ⅱ grade premature infant.
出处
《中国当代医药》
2010年第25期52-53,共2页
China Modern Medicine
关键词
盐酸氨溴索
鼻塞式持续气道正压通气
早产儿肺透明膜病
Ambroxol hydrochloride capsules
Nasal continuous positive airway pressure（NCPAP）
Hyaline membrane disease
